Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Mersana Therapeutics Inc (MRSN)

Mersana Therapeutics Inc (MRSN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 322,980
  • Shares Outstanding, K 96,991
  • Annual Sales, $ 40 K
  • Annual Income, $ -170,060 K
  • 60-Month Beta 2.37
  • Price/Sales 7,105.15
  • Price/Cash Flow N/A
  • Price/Book 1.87
Trade MRSN with:

Options Overview Details

View History
  • Implied Volatility 161.15% ( +74.73%)
  • Historical Volatility 96.92%
  • IV Percentile 98%
  • IV Rank 95.36%
  • IV High 166.61% on 05/04/22
  • IV Low 48.82% on 07/02/21
  • Put/Call Vol Ratio 0.00
  • Today's Volume 1
  • Volume Avg (30-Day) 9
  • Put/Call OI Ratio 0.63
  • Today's Open Interest 1,593
  • Open Int (30-Day) 2,591

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/22
See More
  • Average Estimate -0.53
  • Number of Estimates 5
  • High Estimate -0.48
  • Low Estimate -0.60
  • Prior Year -0.59
  • Growth Rate Est. (year over year) +10.17%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.68 +24.25%
on 05/12/22
3.99 -16.52%
on 05/04/22
-0.23 (-6.46%)
since 04/27/22
3-Month
2.68 +24.25%
on 05/12/22
5.08 -34.45%
on 04/14/22
-0.76 (-18.58%)
since 02/25/22
52-Week
2.68 +24.25%
on 05/12/22
15.34 -78.29%
on 06/07/21
-11.06 (-76.86%)
since 05/27/21

Most Recent Stories

More News
Mersana Therapeutics to Present at Upcoming Investor Conferences

CAMBRIDGE, Mass., May 26, 2022 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ: MRSN), a clinical-stage biopharmaceutical company focused on...

MRSN : 3.33 (+5.71%)
Mersana Therapeutics, Inc. (MRSN) Reports Q1 Loss, Lags Revenue Estimates

Mersana Therapeutics, Inc. (MRSN) delivered earnings and revenue surprises of -90.32% and 89.82%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?...

MRSN : 3.33 (+5.71%)
RETA : 29.63 (+6.58%)
Mersana Therapeutics Provides Business Update and Announces First Quarter 2022 Financial Results

Advanced UpRi development across UPLIFT, UPGRADE, and UP-NEXT clinical trialsPrepared for expected initiation of patient dosing in Phase 1 clinical trials...

MRSN : 3.33 (+5.71%)
Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

CAMBRIDGE, Mass., May 06, 2022 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on...

MRSN : 3.33 (+5.71%)
Certara, Inc. (CERT) Matches Q1 Earnings Estimates

Certara, Inc. (CERT) delivered earnings and revenue surprises of 0% and 2.22%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

CERT : 20.96 (+4.75%)
MRSN : 3.33 (+5.71%)
First Week of MRSN June 17th Options Trading

Investors in Mersana Therapeutics Inc saw new options begin trading this week, for the June 17th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the MRSN options...

MRSN : 3.33 (+5.71%)
Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

CAMBRIDGE, Mass., April 06, 2022 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on...

MRSN : 3.33 (+5.71%)
Mersana Therapeutics to Present Preclinical Data on XMT-1660, XMT-2056 and the Immunosynthen Platform at AACR Annual Meeting

XMT-1660 demonstrates robust activity in preclinical models of breast cancer XMT-2056 demonstrates robust activity as monotherapy, in combination with...

MRSN : 3.33 (+5.71%)
Strength Seen in Sangamo (SGMO): Can Its 9.6% Jump Turn into More Strength?

Sangamo (SGMO) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the...

SGMO : 3.68 (+3.95%)
MRSN : 3.33 (+5.71%)
Mersana Therapeutics to Present an Analysis from the Expansion Cohort of the Phase 1 Trial of Upifitamab Rilsodotin at the Society of Gynecologic Oncology (SGO) Annual Meeting on Women’s Cancer

CAMBRIDGE, Mass., March 15, 2022 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on...

MRSN : 3.33 (+5.71%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Mersana Therapeutics, Inc. is a biotechnology company. It focused on discovering and developing a pipeline of antibody drug conjugates. The company's product candidates include XMT-1522 and XMT-1536 which are in clinical stage. Mersana Therapeutics, Inc. is based in CAMBRIDGE, United States.

See More

Key Turning Points

3rd Resistance Point 3.63
2nd Resistance Point 3.49
1st Resistance Point 3.41
Last Price 3.33
1st Support Level 3.19
2nd Support Level 3.06
3rd Support Level 2.98

See More

52-Week High 15.34
Fibonacci 61.8% 10.50
Fibonacci 50% 9.01
Fibonacci 38.2% 7.52
Last Price 3.33
52-Week Low 2.68

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar